Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Optinose Inc (OPTN)

Optinose Inc (OPTN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 148,716
  • Shares Outstanding, K 53,113
  • Annual Sales, $ 49,120 K
  • Annual Income, $ -99,790 K
  • 60-Month Beta 1.00
  • Price/Sales 2.93
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade OPTN with:

Options Overview

Details
  • Implied Volatility 124.85%
  • Historical Volatility 57.44%
  • IV Percentile 78%
  • IV Rank 45.26%
  • IV High 211.89% on 07/19/21
  • IV Low 52.89% on 05/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 41
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 1,283
  • Open Int (30-Day) 872

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.43
  • Number of Estimates 2
  • High Estimate -0.42
  • Low Estimate -0.43
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +23.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.60 +3.85%
on 07/22/21
3.50 -22.86%
on 06/28/21
-0.57 (-17.43%)
since 06/25/21
3-Month
2.60 +3.85%
on 07/22/21
3.85 -29.87%
on 06/14/21
-1.13 (-29.50%)
since 04/26/21
52-Week
2.60 +3.85%
on 07/22/21
7.04 -61.65%
on 08/11/20
-2.21 (-45.01%)
since 07/24/20

Most Recent Stories

More News
AlayaCare and Option Care Health Announce Joint Technology Collaboration Agreement

AlayaCare, a global home and community care software company, and Option Care Health, Inc. ("Option Care Health") (Nasdaq: OPCH), the largest independent provider of home and alternate site infusion services...

OPTN : 2.70 (-3.57%)
OPCH : 20.53 (-3.34%)
Option Care Health to Announce Second Quarter 2021 Financial Results and Host Conference Call

Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that the company will release...

OPTN : 2.70 (-3.57%)
OPCH : 20.53 (-3.34%)
Insights on the Infusion Therapy Global Market to 2026 - Featuring Pfizer, Baxter International and Option Care Health Among Others

The "Infusion Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

OPTN : 2.70 (-3.57%)
Optinose Technology Inventor Per Djupesland Named Winner of European Inventor Award 2021 for Industry

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced Dr. Per Djupesland received the European Inventor Award...

OPTN : 2.70 (-3.57%)
Thinking about trading options or stock in MicroStrategy, Asana, AMC Entertainment, Ocugen, or Option Care Health?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MSTR, ASAN, AMC, OCGN, and OPCH.

AC : 37.23 (-0.35%)
OPTN : 2.70 (-3.57%)
MSTR : 682.50 (+26.46%)
OCGN : 6.82 (-1.73%)
OPCH : 20.53 (-3.34%)
AMC : 40.29 (+8.92%)
ASAN : 74.15 (+2.53%)
Option Care Health Announces Upsizing and Pricing of Secondary Offering of 15,000,000 Shares of Common Stock

Option Care Health, Inc. ("Option Care Health" or the "Company") (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the "Selling Stockholder") has agreed to sell 15,000,000...

OPTN : 2.70 (-3.57%)
OPCH : 20.53 (-3.34%)
Option Care Health Announces Secondary Offering of 10,000,000 Shares of Common Stock

Option Care Health, Inc. ("Option Care Health" or the "Company") (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the "Selling Stockholder") has agreed to sell 10,000,000...

OPTN : 2.70 (-3.57%)
OPCH : 20.53 (-3.34%)
Experts Issue New Treatment Algorithm for Chronic Rhinosinusitis with Nasal Polyps That Highlights Role of XHANCE® In Stepwise Care

, /PRNewswire/ -- Optinose (NASDAQ:OPTN), a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists, today announced...

OPTN : 2.70 (-3.57%)
Optinose to Present at the Jefferies Virtual Healthcare Conference

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present...

OPTN : 2.70 (-3.57%)
Option Care Health to Participate in Upcoming Virtual Investor Conferences

Option Care Health Inc. ("Option Care Health") (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that John C. Rademacher,...

OPTN : 2.70 (-3.57%)
OPCH : 20.53 (-3.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and...

See More

Key Turning Points

3rd Resistance Point 2.89
2nd Resistance Point 2.85
1st Resistance Point 2.77
Last Price 2.70
1st Support Level 2.65
2nd Support Level 2.61
3rd Support Level 2.53

See More

52-Week High 7.04
Fibonacci 61.8% 5.34
Fibonacci 50% 4.82
Fibonacci 38.2% 4.30
Last Price 2.70
52-Week Low 2.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar